Chlamydiavaccines: recent developments and the role of adjuvants in future formulations

The ‘perfect’ adjuvant, a stronger voice

(2011) Gregory M Glenn   Expert Review of Vaccines

Influenza virosomes as a vaccine adjuvant and carrier system

(2011) Christian Moser et al.   Expert Review of Vaccines

Virus-like particles: innate immune stimulators

(2011) Ramadevi Raghunandan   Expert Review of Vaccines

TLR-7 and -8 agonists as vaccine adjuvants

(2011) Mark A Tomai et al.   Expert Review of Vaccines

Carbohydrate-based immune adjuvants

(2011) Nikolai Petrovsky et al.   Expert Review of Vaccines

Trends in vaccine adjuvants

(2011) Virgil EJC Schijns et al.   Expert Review of Vaccines

MF59 adjuvant: the best insurance against influenza strain diversity

(2011) Derek T O’Hagan et al.   Expert Review of Vaccines

CpG DNA as a vaccine adjuvant

(2011) Christian Bode et al.   Expert Review of Vaccines

Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems

(2011) Nathalie Garçon et al.   Expert Review of Vaccines

Towards aChlamydia trachomatisvaccine: how close are we?

(2010) Melanie Cochrane et al.   Future Microbiology

Chlamydia trachomatisStrains and Virulence: Rethinking Links to Infection Prevalence and Disease Severity

(2010) Gerald I. Byrne   JOURNAL OF INFECTIOUS DISEASES

Contribution of sexually transmitted infections to the sexual transmission of HIV

(2010) Helen Ward et al.   Current Opinion in HIV and AIDS

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households

(2010) Elizabeth N. Ssemanda et al.   PLoS Neglected Tropical Diseases

Chlamydia vaccine candidates and tools for chlamydial antigen discovery

(2009) Daniel D Rockey et al.   Expert Review of Vaccines

CT043, a Protective Antigen That Induces a CD4+ Th1 Response during Chlamydia trachomatis Infection in Mice and Humans

(2009) E. Meoni et al.   INFECTION AND IMMUNITY

T Cell Responses in the Absence of IFN-  Exacerbate Uterine Infection with Chlamydia trachomatis

(2009) D. C. Gondek et al.   JOURNAL OF IMMUNOLOGY

Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor

(2009) Ana Catarina Simonetti et al.   MICROBES AND INFECTION

Endogenous Processing and Presentation of T-cell Epitopes fromChlamydia trachomatiswith Relevance in HLA-B27-associated Reactive Arthritis

(2009) Juan J. Cragnolini et al.   MOLECULAR & CELLULAR PROTEOMICS

Global Elimination of Blinding Trachoma by 2020: Where Are We?

(2009) Sheila West   OPHTHALMIC EPIDEMIOLOGY

A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity

(2009) Cheryl I. Champion et al.   PLoS One

The Arrested Immunity Hypothesis and the Epidemiology of Chlamydia Control

(2009) Robert C. Brunham et al.   SEXUALLY TRANSMITTED DISEASES

Vaccines for Chlamydia infections of the female genital tract

(2008) Louise M Hafner et al.   Future Microbiology

Antigenic Profiling of aChlamydia trachomatisGene‐Expression Library

(2008) Frank Follmann et al.   JOURNAL OF INFECTIOUS DISEASES

Chlamydia trachomatis infection: host immune responses and potential vaccines

(2008) L Hafner et al.   Mucosal Immunology